News NICE to play key role in UK drug fast-track scheme Former GSK CEO Sir Andrew Witty will oversee proceedings.
News FDA to streamline access to consumer genetic tests New regulations require less pre-market data for approval.
Views & Analysis Kick-starting innovation in Glioblastoma Can risk-sharing and real-world evidence can provide traction in treating the brain cancer Glioblastoma?
News Roche's Tecentriq gets three years to prove itself on Cancer... Roche’s Tecentriq has been added to the new-look Cancer Drugs Fund for bladder cancer patients, making it the latest in a recent flurry of drugs to be put on the managed access fund.
News Novo sales up, but CEO warns of fresh US price crackdown Certain US states drafting new pricing legislation
Articles MINT: opportunities in 'frontier' markets? The prospects for pharma in the MINT emerging countries of Mexico, Indonesia, Nigeria and Turkey.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
